Skip to main content
JUBILANT PHARMOVA LIMITED logo

JUBILANT PHARMOVA LIMITED — Investor Relations & Filings

Ticker · JUBLPHARMA ISIN · INE700A01033 LEI · 335800C6LDKWF4HQH833 BSE.NS Manufacturing
Open in API
Filings indexed 1,045 across all filing types
Latest filing 2022-09-05 AGM Information
Country IN India
Listing BSE.NS JUBLPHARMA

About JUBILANT PHARMOVA LIMITED

https://www.jubilantpharmova.com/

Jubilant Pharmova Limited is an integrated global pharmaceutical company operating through three primary segments: Pharmaceuticals, Contract Research and Development Services (CRDS), and Proprietary Novel Drugs. The Pharmaceuticals segment specializes in radiopharmaceuticals for nuclear medicine, allergy immunotherapy, and the development and manufacturing of generic formulations. It also provides Contract Development and Manufacturing Organization (CDMO) services for sterile injectables and non-sterile products. The CRDS division offers comprehensive drug discovery and development solutions to biopharmaceutical companies worldwide. Furthermore, the Proprietary Novel Drugs segment focuses on creating innovative therapies for oncology and autoimmune diseases. The company leverages its advanced manufacturing infrastructure and research capabilities to serve global markets with a focus on complex chemistry and specialized healthcare solutions.

Recent filings

Filing Released Lang Actions
Newspaper Advertisements
AGM Information Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) dated September 5, 2022, concerning the submission of newspaper advertisements related to the 44th Annual General Meeting (AGM) and e-voting information. It mentions the dispatch of the Notice of the 44th AGM and the Annual Report for FY 2021-22. The content focuses on the announcement and advertisement of the AGM and related voting information rather than the full AGM materials or the Annual Report itself. The document length is about 15,000 characters, but the content is primarily about the advertisement and information dissemination for the AGM, not the AGM presentation materials or the full Annual Report. Therefore, this fits best under AGM Information (AGM-R) as it relates to materials shared or announced for the AGM, specifically the newspaper advertisements and e-voting details.
2022-09-05 English
Annual General Meeting
AGM Information Classification · 95% confidence The document is a notice dated September 3, 2022, from Jubilant Pharmova Limited addressed to stock exchanges regarding the 44th Annual General Meeting (AGM) scheduled for September 26, 2022. It mentions the AGM notice and the Annual Report for the financial year 2021-22 have been sent to members and are available on the company's website. The document includes details about the AGM, voting procedures, and dividend declaration subject to shareholder approval at the AGM. It also encloses the AGM notice and Annual Report for FY 2021-22. The document is primarily an announcement of the AGM and the availability of the Annual Report, not the full Annual Report itself. The length is about 15,000 characters, but the content is focused on the notice and related information rather than the full report. Therefore, according to the "Menu vs Meal" rule, this document is best classified as AGM Information (AGM-R) because it contains the AGM notice and related materials shared for the AGM, including the Annual Report as an attachment or reference, but is not the full Annual Report itself.
2022-09-03 English
Newspaper Advertisements
Report Publication Announcement Classification · 95% confidence The document is a letter dated August 30, 2022, addressed to stock exchanges (BSE and NSE) regarding the publication of information about the 44th Annual General Meeting (AGM) of Jubilant Pharmova Limited scheduled for September 26, 2022. It mentions that the Notice of the AGM and the Annual Report for the financial year 2021-22 will be sent to shareholders and made available on the company's website in due course. The document also encloses copies of advertisements published in newspapers pursuant to regulatory circulars. The content is primarily an announcement about the upcoming AGM and the availability of related materials, not the AGM materials themselves or the Annual Report. The document length is about 15,000 characters, but the content is focused on informing about the AGM and the report availability, consistent with a report publication announcement rather than the report itself. Therefore, the appropriate classification is Report Publication Announcement (RPA).
2022-08-30 English
General updates
Regulatory Filings Classification · 95% confidence The document is a press release dated August 26, 2022, from Jubilant Pharmova Limited announcing the receipt of an Establishment Inspection Report (EIR) with Voluntary Action Indicated (VAI) status from the USFDA for a subsidiary's manufacturing facility. It is addressed to stock exchanges and references compliance with SEBI regulations. The content is an announcement of a regulatory inspection outcome rather than a detailed financial report, management discussion, or earnings release. The document is about a regulatory update and does not contain financial statements or detailed analysis. It is not a full report but a press release announcing a regulatory event. Therefore, the most appropriate classification is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2022-08-26 English
General updates
Capital/Financing Update Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding the early redemption of senior notes by a wholly owned subsidiary. It details the redemption of debt securities, the amount redeemed, and confirms that no amount remains outstanding. There is no financial statement or detailed financial analysis present, and the document is relatively short (1634 characters). This fits the description of a Capital/Financing Update, as it informs about a financing activity (early redemption of notes). It is not an announcement of a report publication, nor a full financial report, nor a regulatory certification. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2022-08-19 English
Transcript of Analysts/Institutional Investor Meet/Con. Call
Call Transcript Classification · 100% confidence The document is a detailed transcript of an earnings conference call for the quarter ended June 30, 2022, as indicated by the subject line and the content. It includes management commentary, financial performance discussion, segment-wise revenue and EBITDA details, and Q&A session participants. The document is about 15,000 characters long, contains substantive financial data and analysis, and is not merely an announcement or a brief summary. It is not a formal earnings release (which would be shorter and more summary-like), but a full transcript of the earnings call. Therefore, the appropriate classification is Call Transcript (CT).
2022-08-08 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.